previous compound ID: 2129 next compound
InChIKey: SSAJNPNVUYMUCI-UHFFFAOYSA-N
SMILES: CCN(CC)CCOC(=O)C(CC1CCCO1)CC2=CC=CC3=CC=CC=C32.C(=O)(C(=O)O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "D Rotin" "DY Thomas" "SD Macknight" "JW Hanrahan" "R Robert" "GW Carlile" "J Liao" "J Goepp" "E Matthes"

chemical graph of compound 2129





CID is 18542
synonyms found at PubChem are:
Dubimax, Dusodril, Gevatran, Praxilene, Iridus, Nafronyl acid oxalate, Naphtidrofuryl oxalate, Nafronyl oxalate [USAN], EINECS 221-703-0, NSC 225233, LS 121, EU-1806, 2-(Diethylamino)ethyl tetrahydro-alpha-(1-naphthylmethyl)-2-furanpropionate oxalate (1:1), 2-Furanpropanoic acid, tetrahydro-alpha-(1-naphthalenylmethyl)-, 2-(diethylamino)ethyl ester, ethanedioate (1:1), 2-Furanpropionic acid, tetrahydro-alpha-(1-naphthylmethyl)-, 2-(diethylamino)ethyl ester, oxalate (1:1), Diethyl(2-(2-(1-naphthylmethyl)-3-(tetrahydro-2-furyl)propionyloxy)ethyl)ammonium hydrogen oxalate, LS-121, AC1L2CA6, C24H33NO3.C2H2O4, MolPort-000-815-884, MCULE-2856913118, LS-70565, 2-Furanpropionic acid, tetrahydro-alpha-(1-naphthylmethyl)-, 2-(diethylamino)ethyl ester,oxalate (1:1), 26263-44-5, diethyl-[2-[2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoyl]oxyethyl]azanium; 2-hydroxy-2-oxoacetate, Nafronyl oxalate, 3200-06-4, Naftidrofuryl oxalate, Nafronyl oxalate salt, Naftidrofuryl (oxalate), 2-(Diethylamino)ethyl 3-(naphthalen-1-yl)-2-((tetrahydrofuran-2-yl)methyl)propanoate oxalate, DSSTox_CID_25533, DSSTox_RID_80935, DSSTox_GSID_45533, naftidrofuryl hydrogen oxalate, alpha-[1-Naphthylmethyl]-2-tetrahydrofuranpropionic acid diethylaminoethyl ester, CHEMBL1439099, Nafronyl oxalate salt, analytical standard, SMR000539007, CAS-3200-06-4, NSC225233, SR-01000789261, Clarantin, 2-(diethylamino)ethyl 2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoate;oxalic acid, Naftidrofuryloxalate, Praxilene (TN), Prestwick_696, Naftidrofuryl(oxalate), 2-(Diethylamino)ethyl tetrahydro-.alpha.-(1-naphthylmethyl)-2-furanpropionate oxalate (1:1), AC1L7MCR, naftidrofuryl; oxalic acid, NCGC00016982-01, MLS000766889, MLS001032044, MLS001173344, MLS002222244, SCHEMBL123848, SPECTRUM1503419, DTXSID6045533, CTK8C4926, HMS501A20, KS-00001FAU, MolPort-003-666-484, HMS1569K15, HMS1922C14, HMS2093E15, HMS2096K15, HMS2875A08, HMS3713K15, Pharmakon1600-01503419, BCP19865, HY-B1107, Tox21_110724, ANW-73527, CCG-40305, NSC758462, AKOS015960731, Tox21_110724_1, API0006883, CS-4704, NSC-225233, NSC-758462, NCGC00095050-01, NCGC00095050-02, NCGC00178213-05, 4,4-Diaminostilbene-2,3-Disulfonic Acid, AC-12093, O219, KB-224003, ST2409387, TC-162272, FT-0629863, D05107, C-54995, J-018595, SR-01000789261-2, SR-01000789261-3, 2-Furanpropionic acid, 2-(diethylamino)ethyl ester oxalate (1:1), 2-Furanpropionic acid, 2-(diethylamino)ethyl esteroxalate (1:1), 2-Furanpropanoic acid, 2-(diethylamino)ethyl ester, ethanedioate (1:1), 2-(diethylamino)ethyl 2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoate,oxalic acid, 2-diethylaminoethyl 2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoate; oxalic acid